Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
The classification of Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
Compounding Pharmacy is widely used for consumers aged 18 and younger, consumers aged 19 to 44, consumers aged 45 to 64, consumers aged 65 and older. The most proportion of compounding pharmacy is consumers aged 45 to 64, and the proportion in 2018 is 40.3%.
Americas is the largest market for compounding pharmacy, with a market share nearly 60.5% in 2018. Following America, Europe is the second largest market with the consumption market share of 25.5%.
In 2018, the global Compounding Pharmacy market size was 10600 million US$ and it is expected to reach 12800 million US$ by the end of 2025, with a CAGR of 2.7% during 2019-2025.

This report focuses on the global Compounding Pharmacy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Compounding Pharmacy development in United States, Europe and China.

The key players covered in this study
Fagron
CAPS
Wedgewood Pharma
NewCo Pharma GmbH
PharMEDium Services
Advanced Pharma
Dougherty’s Pharmacy
Institutional Pharmacy Solutions
Triangle Compounding Pharmacy
Olympia Pharmacy
Lorraine’s Pharmacy
Village Compounding Pharmacy

Market segment by Type, the product can be split into
PIA
PAA
CUPM
PDA
SAPM

Market segment by Application, split into
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Compounding Pharmacy status, future forecast, growth opportunity, key market and key players.
To present the Compounding Pharmacy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Compounding Pharmacy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.